When the SARS-nCoV-2 pandemic commenced in Wuhan, China at the end of 2019, there were few available clinical guidelines to deploy, let alone adapt and adopt to treat the surge of COVID-19 patients. Doctors in China, Italy, across Europe and the US began to observe deaths due to blood clots. The aim of this study is to first explain how clinical guidelines, on which bedside clinicians have grown accustomed, can be created in the midst of a pandemic through a scoping review of the evolving scientific literature of the pathophysiology of the COVID-19 hypercoagulable state. The second, following the evidence from the scoping review, is to create comprehensive VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 patients. These clinical guidelines will enable all providers to have a basis to prevent blood clots from forming that have lead to death from heart attack, stroke and pulmonary embolism due to COVID-19.
About the Journal
Disaster Medicine and Public Health Preparedness is the first comprehensive and authoritative journal emphasizing public health preparedness and disaster response for all health care and public health professionals globally. The journal seeks to translate science into practice and integrate medical and public health perspectives. DMPHP is the official journal of the Society for Disaster Medicine and Public Health.
About the Society
The Society for Disaster Medicine and Public Health aims to evolve a discipline around disaster medicine and public health. The society's goal is to improve global health security, with the involvement and development of global health professionals and others who are involved in responding to and or managing significant events. The mission of the SDMPH is to advance and promote excellence in education, training and research in disaster medicine and public health for all potential health system responders based on sound educational principles, scientific evidence and best clinical and public health practices.